NO20043007L - Farmasoytisk suspensjon for oral administrering - Google Patents

Farmasoytisk suspensjon for oral administrering

Info

Publication number: NO20043007L
Authority: NO; Norway
Prior art keywords: oral administration; pharmaceutical suspension; pharmaceutical; suspension; oral
Prior art date: 2001-12-20

Application number

NO20043007A

Other languages

English (en)

Inventor

Guang Wei Lu

Po-Chang Chiang

Original Assignee

Pharmacia Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-20

Filing date

2004-07-15

Publication date

2004-07-15

2004-07-15 Application filed by Pharmacia Corp filed Critical Pharmacia Corp

2004-07-15 Publication of NO20043007L publication Critical patent/NO20043007L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20043007A 2001-12-20 2004-07-15 Farmasoytisk suspensjon for oral administrering NO20043007L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US34259901P	2001-12-20	2001-12-20
PCT/US2002/039186 WO2003053403A2 (en)	2001-12-20	2002-12-09	Pharmaceutical suspension for oral administration

Publications (1)

Publication Number	Publication Date
NO20043007L true NO20043007L (no)	2004-07-15

Family

ID=23342498

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20043007A NO20043007L (no)	2001-12-20	2004-07-15	Farmasoytisk suspensjon for oral administrering

Country Status (16)

Country	Link
US (1)	US20030157172A1 (no)
EP (1)	EP1455752A2 (no)
JP (1)	JP2005516943A (no)
KR (1)	KR20040073493A (no)
CN (1)	CN1620282A (no)
AU (1)	AU2002364146A1 (no)
BR (1)	BR0215261A (no)
CA (1)	CA2470912A1 (no)
CO (1)	CO5590886A2 (no)
IL (1)	IL162510A0 (no)
MX (1)	MXPA04006165A (no)
NO (1)	NO20043007L (no)
PL (1)	PL371133A1 (no)
RU (1)	RU2004118493A (no)
WO (1)	WO2003053403A2 (no)
ZA (1)	ZA200404788B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9101540B2 (en) *	2002-04-12	2015-08-11	Alkermes Pharma Ireland Limited	Nanoparticulate megestrol formulations
ATE552825T1 (de)	2006-04-26	2012-04-15	Rosemont Pharmaceuticals Ltd	Flüssige orale zusammensetzungen
US8309138B2 (en)	2007-02-16	2012-11-13	Aska Pharmaceutical Co., Ltd.	Pharmaceutical composition comprising microparticle oily suspension
US9119819B2 (en)	2008-04-30	2015-09-01	Wockhardt Ltd.	Oral liquid compositions of rhein or diacerein
WO2011107855A2 (en)	2010-03-04	2011-09-09	Torrent Pharmaceuticals Limited	Sustained release oral liquid suspension dosage form
EP3302430A4 (en) *	2015-05-29	2019-05-29	codaDose Incorporated	Liquid Formulations of Celecoxib for Oral Administration
ITUB20155193A1 (it) *	2015-11-03	2017-05-03	Italfarmaco Spa	Sospensioni orali di Givinostat fisicamente e chimicamente stabili
KR200486813Y1 (ko)	2018-02-22	2018-08-02	㈜제이아이테크	핸드 파레트 트럭
KR102145022B1 (ko) *	2018-08-14	2020-08-14	동아제약 주식회사	이부프로펜의 현탁액 조성물 및 투여 제형

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2904469A (en) *	1957-07-29	1959-09-15	Johnson & Johnson	Stabilized aqueous suspension of salicylamide
US3041239A (en) *	1959-05-28	1962-06-26	Johnson & Johnson	Stable aqueous salicylamide composition and method of preparing same
US3326755A (en) *	1965-06-15	1967-06-20	Warner Lambert Pharmaceutical	Alginate containing antacid compositions
IT1209276B (it) *	1980-11-05	1989-07-16	Magis Farmaceutici	Composizione farmaceutica per la somministrazione orale del metilestere dell'acido 13a-etil-2,3,5,6,12,13,13a,13b-ottaidro-12-idrossi1h-indolo-[3,2,1-de] pirido [3,2,1-ij] [1,5] naftiridina -12-carbossilico
DK130287D0 (da) *	1987-03-13	1987-03-13	Benzon As Alfred	Oralt praeparat
US5552160A (en) *	1991-01-25	1996-09-03	Nanosystems L.L.C.	Surface modified NSAID nanoparticles
US5976570A (en) *	1993-12-21	1999-11-02	Applied Analytical Industries, Inc.	Method for preparing low dose pharmaceutical products
US5455049A (en) *	1995-01-04	1995-10-03	Ascent Pharmaceuticals, Inc.	Terfenadine oral powder
US5591456A (en) *	1995-02-10	1997-01-07	Nanosystems L.L.C.	Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer
US5718919A (en) *	1995-02-24	1998-02-17	Nanosystems L.L.C.	Nanoparticles containing the R(-)enantiomer of ibuprofen
CA2227314A1 (en) *	1997-01-24	1998-07-24	Hoechst Aktiengesellschaft	Preparation of concealed taste preparations of antibacterially active quinolone derivatives
US6664287B2 (en) *	2000-03-15	2003-12-16	Bethesda Pharmaceuticals, Inc.	Antioxidants

2002
- 2002-12-09 MX MXPA04006165A patent/MXPA04006165A/es unknown
- 2002-12-09 CA CA002470912A patent/CA2470912A1/en not_active Abandoned
- 2002-12-09 RU RU2004118493/15A patent/RU2004118493A/ru not_active Application Discontinuation
- 2002-12-09 EP EP02799220A patent/EP1455752A2/en not_active Withdrawn
- 2002-12-09 BR BR0215261-4A patent/BR0215261A/pt not_active IP Right Cessation
- 2002-12-09 AU AU2002364146A patent/AU2002364146A1/en not_active Abandoned
- 2002-12-09 WO PCT/US2002/039186 patent/WO2003053403A2/en not_active Application Discontinuation
- 2002-12-09 KR KR10-2004-7009567A patent/KR20040073493A/ko not_active Application Discontinuation
- 2002-12-09 JP JP2003554162A patent/JP2005516943A/ja not_active Withdrawn
- 2002-12-09 IL IL16251002A patent/IL162510A0/xx unknown
- 2002-12-09 CN CNA028281799A patent/CN1620282A/zh active Pending
- 2002-12-09 US US10/314,684 patent/US20030157172A1/en not_active Abandoned
- 2002-12-09 PL PL02371133A patent/PL371133A1/xx not_active Application Discontinuation
2004
- 2004-06-17 ZA ZA200404788A patent/ZA200404788B/en unknown
- 2004-06-17 CO CO04056453A patent/CO5590886A2/es not_active Application Discontinuation
- 2004-07-15 NO NO20043007A patent/NO20043007L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2470912A1 (en)	2003-07-03
WO2003053403A3 (en)	2004-02-26
RU2004118493A (ru)	2005-03-27
MXPA04006165A (es)	2004-11-01
WO2003053403A2 (en)	2003-07-03
CN1620282A (zh)	2005-05-25
JP2005516943A (ja)	2005-06-09
KR20040073493A (ko)	2004-08-19
US20030157172A1 (en)	2003-08-21
ZA200404788B (en)	2005-09-01
IL162510A0 (en)	2005-11-20
EP1455752A2 (en)	2004-09-15
PL371133A1 (en)	2005-06-13
CO5590886A2 (es)	2005-12-30
AU2002364146A1 (en)	2003-07-09
BR0215261A (pt)	2004-12-07

Publication	Publication Date	Title
EE05581B1 (et)	2012-10-15	Aripiprasooli ravimlahus peroraalseks manustamiseks
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
EE200300416A (et)	2003-12-15	Ravimvorm
NO20033384D0 (no)	2003-07-29	Farmasöytisk formulering
PT1501534E (pt)	2006-09-29	Formulacoes farmaceuticas
NO20033815L (no)	2003-09-09	Farmasöytiske salter
FI20011478A0 (fi)	2001-07-05	Farmaseuttinen koostumus
IS2580B (is)	2010-02-15	Platínuafleiða lyfjasamsetningar
DK1414409T3 (da)	2007-06-11	Stabiliseret oral suspensionsformulering
NO20035627D0 (no)	2003-12-15	Farmasöytisk formulering
NO20035315D0 (no)	2003-11-28	Farmasöytiske kombinasjoner
NO20014738L (no)	2001-10-23	Tolperisonholdig farmasöytisk preparat for oral administrering
FI20022128L (fi)	2003-06-06	Farmaseuttinen koostumus
NO20034556L (no)	2003-12-10	Imidazotriazinon-holdige sammensetninger for nasal administrering
DE60217390D1 (de)	2007-02-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20043007L (no)	2004-07-15	Farmasoytisk suspensjon for oral administrering
ITMI20011240A0 (it)	2001-06-13	Farmaci per le vasculopatie
AU2002346457A8 (en)	2003-06-10	Pharmaceutical formulations comprising indolinone derivatives
ITMI20011744A0 (it)	2001-08-09	Farmaci per le vasculopatie
DE10291905D2 (de)	2004-05-27	Pharmazeutische Zusammensetzung
FR2791888B1 (fr)	2004-10-08	Suspension pharmaceutique buvable
FI20012242A0 (fi)	2001-11-19	Uudet farmaseuttiset yhdisteet
DE10107261B4 (de)	2005-03-10	Pharmazeutische Zusammensetzung
NO20041236L (no)	2004-03-24	Farmasoytisk formulering
SE0103116D0 (sv)	2001-09-17	Pharmaceutical combination

Legal Events

Date	Code	Title	Description
2007-08-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application